phase 1
ii 1
study 1
alisertib 1
selective 1
aurora 1
kinase 1
inhibitor 1
relapsed 1
refractory 1
aggressive 1
b 3
tcell 1
nonhodgkin 1
lymphomas 1
syk 1
inhibition 1
fostamatinib 1
leads 1
transitional 1
lymphocyte 1
depletion 1
omip 1
phenotypic 1
analysis 1
human 1
memory 1
cells 1
